Module 1A - Donor information (References)

NewsFlash

The final MIATA guidelines have been published in Immunity on June 26, 2012. Please check this website and publication for the ready-to-use guidelines.

Main Menu

web hosting

Module 1A – Donor information - References (suggested by members of the MIATA community)

(If you have relevant references that provide guidance on the donor information that should be provided depending on the context of the study as required in Module 1, please send them to This e-mail address is being protected from spambots. You need JavaScript enabled to view it for listing.)

The following table information was compiled and the table provided by Steffen Walter, Immatics.

Donor information shown to be relevant for T-cell data	Comment	Link	Suggested by
-	Suggestion of admission criteria for immunogerontological studies based on donor information.	http://www.ncbi.nlm.nih.gov/pubmed/6513613	Graham Pawelec
Age, State of Health, Smoking, Medication	Evaluation of admission criteria for immunogerontological studies based on donor information.	http://www.ncbi.nlm.nih.gov/pubmed/2205767	Graham Pawelec
Age	Discussion of dietary factors, age-associated diseases	http://www.ncbi.nlm.nih.gov/pubmed/9476675	Graham Pawelec
Age, CMV infection (review)		http://www.ncbi.nlm.nih.gov/pubmed/20855876	Graham Pawelec
CMV infection, genetic factors		http://www.ncbi.nlm.nih.gov/pubmed/19535233	Graham Pawelec
Age, CMV infection (review)		http://www.ncbi.nlm.nih.gov/pubmed/20727987	Graham Pawelec
-	Healthy donor HIV vaccine study. Donor demographics include gender, HIV risk associated parameters, ethnicity, age	http://www.ncbi.nlm.nih.gov/pubmed/17106277	Guido Ferrari
Time to infection, selection of escape mutants	Acute HIV-1 infection study. Donor demographics include Age, gender, class I HLA alleles, HIV transmission, Fiebig stage, CD4 slope, virus load.	http://www.ncbi.nlm.nih.gov/pubmed/21347345	Guido Ferrari
-	TB vaccine studies: definition of healthy, latent tuberculosis or active tuberculosis	http://www.ncbi.nlm.nih.gov/pubmed/21256189	Simone Joosten
Dose and route of administration	Healthy donor HIV vaccine study. Donor demographics include Risk factor for HIV, Age, Gender, Ethnicitiy, Body Weight.	http://www.ncbi.nlm.nih.gov/pubmed/21603651	Josephine Cox
-	Early HIV-1 infection: association with HLA variants, age, gender, HIV-1 subtypes, duration of infection (no T-cell data in papaer)	http://www.ncbi.nlm.nih.gov/pubmed/21715491	Josephine Cox
-	Consolidated Stardards Of Reporting Trials	http://www.consort-statement.org/	Josephine Cox
HLA –DR, -DQ typing	Vaccination with promiscuous CD4+ T-cell epitope:	http://www.ncbi.nlm.nih.gov/pubmed/21858810	Hans-Georg Rammensee
HLA-DR typing	Autoimmune T-cell responses in sarcoidosis	http://www.ncbi.nlm.nih.gov/pubmed/19786367	Hans-Georg Rammensee
Gender was associated with Treg levels		http://www.ncbi.nlm.nih.gov/pubmed/18414854	Pedro Romero
-	Differences of antibody titers and plasmablasts between old and young influenza vaccinated individuals (no T-cell data)	http://www.ncbi.nlm.nih.gov/pubmed/21785218	Pedro Romero
Size of lesions in HPV16-induced vulvar intraepithelial neoplasia was associated with HPV-16 specific immune responses and Tregs		http://www.ncbi.nlm.nih.gov/pubmed/20547850	Cornelis Melief

miataproject.org, Powered by Joomla! and designed by SiteGround Joomla Templates